Circular / Advisories
Stay informed with the latest regulatory updates, official announcements, and industry advisories from UPANR.
Revised Drug Labeling Guidelines
The regulatory authorities have issued updated guidelines regarding drug labeling requirements for pharmaceutical manufacturers. All member companies are advised to ensure compliance with the new standards to avoid penalties.
02 April 2026
UPANR Annual General Meeting Notice
This is to inform all members about the upcoming Annual General Meeting (AGM). Members are requested to attend and participate in key discussions regarding industry growth and association activities.
25 March 2026
Advisory on Ethical Marketing Practices
UPANR advises all pharmaceutical companies to strictly follow ethical marketing standards. Misleading promotions and non-compliant practices should be avoided to maintain industry credibility.